1. Home
  2. TXG vs IRON Comparison

TXG vs IRON Comparison

Compare TXG & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

N/A

Current Price

$18.61

Market Cap

2.8B

Sector

Industrials

ML Signal

N/A

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

N/A

Current Price

$79.72

Market Cap

3.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TXG
IRON
Founded
2012
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.0B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
TXG
IRON
Price
$18.61
$79.72
Analyst Decision
Hold
Strong Buy
Analyst Count
14
12
Target Price
$16.18
$110.08
AVG Volume (30 Days)
2.7M
525.4K
Earning Date
02-12-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$641,814,000.00
N/A
Revenue This Year
$4.94
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.92
N/A
52 Week Low
$6.78
$30.82
52 Week High
$23.56
$99.50

Technical Indicators

Market Signals
Indicator
TXG
IRON
Relative Strength Index (RSI) 38.96 52.49
Support Level $17.37 $76.00
Resistance Level $20.49 $83.93
Average True Range (ATR) 1.18 4.03
MACD -0.60 0.69
Stochastic Oscillator 8.89 79.74

Price Performance

Historical Comparison
TXG
IRON

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: